Loading page…
Chugai Pharmaceutical Co Ltd 2024 Integrated Report
Company: Chugai Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2024
Type: Integrated Report
Pages: 49
The report presents Chugai's 2024 results alongside its centennial year, reporting revenue of ¥1,170.6 billion and operating profit of ¥556.1 billion. It highlights the global launch of PiaSky and U.S. approval of NEMLUVIO, as well as progress under TOP I 2030. The report also describes a 2024 materiality review that condensed 26 issues into 16 and used double materiality as an evaluation basis.
Indicators available in this report: